Primary tumor–derived lactate primes prostate cancer cells for a dormant fate
Science Advances · 2026
DOI: 10.1126/sciadv.aeb8595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Luigi Ippolito und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Lactic Acid. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Associazione Italiana per la Ricerca sul Cancro, European Union, Italian Minister of University and Research.
Abstract (Originalsprache)
The metastatic outcome depends on the state of disseminated cancer cells (DCCs) leading to overt metastasis or undergoing dormancy. Before distant organ colonization, primary tumor microenvironment may shape the decision between proliferation and dormancy. Here, we identify lactic acid (LA), a highly abundant environmental metabolite at the primary site in prostate cancer (PCa), as a key inducer of dormant state. LA-uploading PCa cells undergo a proliferation delay, associated with stemness, therapy tolerance, and invasiveness through the nuclear receptor subfamily 2 group F member 1 (COUP-TF1/NR2F1) activation. These traits rely on LA-driven accumulation of lipid droplets (LDs), which serve as reservoirs of lipid-derived acetyl moieties essential for histone acetylation. Notably, the epigenetic reader BRD4 is essential for COUP-TF1 expression and for establishing and maintaining dormancy. In metastatic sites, where LA levels are low, dormant features are lost, allowing DCCs to support metastatic growth. Last, targeting LA-mediated LD formation or BRD4 activation prevents dormancy entry, reducing PCa cell adaptability and increasing vulnerability to antiproliferative therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy.
- Department of Health Sciences, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.
ORCID-Profile: Luigi Ippolito, Erica Pranzini, Marta Iozzo, Giacomo Venditti, Sara Roccabianca, Elisa Pardella, Matteo Lulli, Alice Santi, Gabriella Nesi, Elisa Giannoni, Paola Chiarugi
Förderung
- Associazione Italiana per la Ricerca sul Cancro
- European Union
- Italian Minister of University and Research
Zitieren
APA
Ippolito, L., Pranzini, E., Gangarossa, G., Iozzo, M., Comito, G., Venditti, G., Roccabianca, S., Pardella, E., Lulli, M., Santi, A., Nesi, G., Giannoni, E., & Chiarugi, P. (2026). Primary tumor–derived lactate primes prostate cancer cells for a dormant fate. Science Advances. https://doi.org/10.1126/sciadv.aeb8595
Vancouver
Ippolito L, Pranzini E, Gangarossa G, Iozzo M, Comito G, Venditti G, et al. Primary tumor–derived lactate primes prostate cancer cells for a dormant fate. Science Advances. 2026. doi:10.1126/sciadv.aeb8595
BibTeX
@article{Ippolito2026,
author = {Ippolito, Luigi and Pranzini, Erica and Gangarossa, Giulia and Iozzo, Marta and Comito, Giuseppina and Venditti, Giacomo and Roccabianca, Sara and Pardella, Elisa and Lulli, Matteo and Santi, Alice and Nesi, Gabriella and Giannoni, Elisa and Chiarugi, Paola},
title = {Primary tumor–derived lactate primes prostate cancer cells for a dormant fate},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aeb8595}
}
EUVIMED